Biotech Values

[stuartscott8900]

dew

do you attribute the almost 20% decline in fmi over last 5 days to disappointment over the number of tests performed in 3rd qtr and/or projections of tests moving forward?

and on enta..with approval baked into the price,what will it take to see a pop in the stock.is it a matter of the analysts upgrading there expectations of the abbv/enta HCV market share from 15-20% to 35-40%?

And if they don't get a 12 week label for cirrhotic patients do you think we will see a downturn in stock price,or is that news not expected to occur?

always appreciate your input.